| NCT ID | NCT07649278 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Substance Related Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-07-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine the feasibility, appropriateness, and acceptability of a bundle of smartphone-based tools for lowering overdose risk. 40 participants will be enrolled and can expect to be on study for up to 9 months.
Eligibility Criteria
Inclusion Criteria (Pilot Participant): * Be at least 18 years old * Be able to read and write in English * Report drug use in the past 30 days, defined as * Any use of illicit stimulants, opioids, OR * Use of prescription opioids by a route other than "by mouth/swallowed" * Additionally report recent drug use of at least twice in the past 7 days * Express perceived unmet needs for harm reduction services Inclusion Criteria (Peer Mentor Participant): * Be at least 18 years old * Be able to read and write in English * Have served as a member of the existing Community Leadership Team. Exclusion Criteria: * Are under the age of 18 * Have impaired decision making capacity at the time of screening * Do not have the ability to participate in screening and enrollment activities in any one of the following ways: * Traveling to their nearest participating Vivent Health health center * Coordinating a visit with the Vivent Health harm reduction mobile unit * Accessing and completing the online screening survey on a personal wifi/internet enabled device
Contact & Investigator
Rachel Gicquelais, PhD, MPH
PRINCIPAL INVESTIGATOR
UW School of Medicine and Public Health
Frequently Asked Questions
Who can join the NCT07649278 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Related Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07649278 currently recruiting?
Yes, NCT07649278 is actively recruiting participants. Contact the research team at enhance@medicine.wisc.edu for enrollment information.
Where is the NCT07649278 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT07649278 clinical trial?
NCT07649278 is sponsored by University of Wisconsin, Madison. The principal investigator is Rachel Gicquelais, PhD, MPH at UW School of Medicine and Public Health. The trial plans to enroll 40 participants.